For example, efforts are already underway to develop APOC2 mimetic peptides, aimed at restoring normal lipid metabolism by enhancing lipoprotein lipase (LPL) activity, which holds promise not only for treating cardiovascular diseases but also for addressing lipid-related brain health issues.74 Another example is the TUBGCP5 gene involved in microtubule organization. The gene discussed is APOC2; the disease is cardiovascular disorder.